Study Summary
This trial will test an intervention to help women living with HIV/AIDS with a history of violence increase their adherence to HIV treatment, regulate emotions and reduce PTSD symptoms.
- HIV/AIDS
Treatment Effectiveness
Effectiveness Progress
Study Objectives
4 Primary · 0 Secondary · Reporting Duration: 4-, 8-, and 12-month post-randomization
Trial Safety
Trial Design
2 Treatment Groups
Women SHINE
1 of 2
Control Arm
1 of 2
Experimental Treatment
Non-Treatment Group
360 Total Participants · 2 Treatment Groups
Primary Treatment: Women SHINE · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Female Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any open slots available in this clinical experiment?
"Correct. According to information found on clinicaltrials.gov, this medical research is actively seeking participants as of March 15th 2023; the study was initially posted on November 15th 2022. 360 patients from 1 site are needed for the trial's completion." - Anonymous Online Contributor
How many volunteers are participating in this trial?
"Affirmative. The information on clinicaltrials.gov displays that this experiment is now recruiting candidates. It was originally posted on November 15th 2022 and has been recently updated as of March 15th 2023 - with the aim to enrol 360 people in a single location." - Anonymous Online Contributor